» Articles » PMID: 20090225

High Incidence of Epstein Barr Virus Infection in Childhood Acute Lymphocytic Leukemia: a Preliminary Study

Overview
Specialties Microbiology
Pathology
Date 2010 Jan 22
PMID 20090225
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Epstein Barr virus (EBV) has a unique association with several human malignancies, especially lymphoproliferative disorders, mainly lymphomas in adults. There is paucity of data pertaining to EBV association with various cancers in India .

Objective: The study aims to investigate the association of EBV in childhood leukemia.

Material And Methods: Patients attending pediatric oncology services of the referral center have been included in the study. Twenty-five consecutive pediatric patients with acute lymphocytic lukemia (ALL) were subjected to EBV studies employing sensitive polymerase chain reaction followed by hybridization for presence of Bam H1-W region of EBV genome and detection of anti Z EBV replication activator (ZEBRA) antibodies using Western blot. Positive control included a case of Burkitt's lymphoma and infectious mononucleosis each. Raji cells were used as positive control with each test.

Results: The PCR for EBV was positive in 8/25 patients of ALL. Western blot test using anti ZEBRA antibodies was positive in 5/25(20%) cases of ALL. Considering PCR as the gold standard, 32% of the children with ALL had evidence of active EBV replication. The positive controls were consistently positive. None of the 30 healthy laboratory controls, 22 age matched disease controls, 12 cases of AML and 15 cases of multiple myeloma were positive either by PCR or Western blots assays (P < 0. 01). There was no statistically significant correlation between duration of therapy and EBV positivity (P > 0.05).

Conclusion: These studies indicate that a significant number of patients with ALL show evidence of active EBV replication.

Citing Articles

Evaluation of Clinical and Hematological Findings of Patients with Acute and Reactivated EBV Infection.

Bahadir A, Tekin T, Gayretli Aydin Z, Reis G, Erduran E Indian J Hematol Blood Transfus. 2025; 41(1):89-95.

PMID: 39917498 PMC: 11794905. DOI: 10.1007/s12288-024-01792-0.


Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies.

Olejarz W, Sadowski K, Szulczyk D, Basak G Int J Mol Sci. 2024; 25(14).

PMID: 39062986 PMC: 11276786. DOI: 10.3390/ijms25147743.


Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond.

Aureli A, Marziani B, Venditti A, Sconocchia T, Sconocchia G Cancers (Basel). 2023; 15(13).

PMID: 37444456 PMC: 10340788. DOI: 10.3390/cancers15133346.


Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: Expression Emerges as a Survival-Related Gene.

Zapata-Garcia J, Riveros-Magana A, Ortiz-Lazareno P, Hernandez-Flores G, Jave-Suarez L, Aguilar-Lemarroy A Diagnostics (Basel). 2022; 12(11).

PMID: 36428851 PMC: 9689318. DOI: 10.3390/diagnostics12112788.


Acute lymphoblastic leukemia: a comprehensive review and 2017 update.

Terwilliger T, Abdul-Hay M Blood Cancer J. 2017; 7(6):e577.

PMID: 28665419 PMC: 5520400. DOI: 10.1038/bcj.2017.53.